2 results
Approved WMOCompleted
The objective of the trial is to assess the long-term safety and tolerability of intracerebroventricular administration of sNN0029 infusion solution at a dose of 4 µg/day delivered via a Medtronic SynchroMed® II Infusion System.
Approved WMOWill not start
The objective of this study is to assess the safety and feasibility of WATS for esophageal sampling after nCRT in patient with esophageal cancer.